In the first trial of 60 women at increased risk of OHSS, 75% of patients had an AMH ≥40 pmol/L, all patients had an AFC ≥23, and 42% had an AFC ≥40 (26). This evidence concerns the gene AMH and ovarian hyperstimulation syndrome.